跳至主要内容
临床试验/NCT05973409
NCT05973409已完成不适用

Evaluation of Onefit Scleral Lenses in the Mangement of Dry Eye

CooperVision International Limited (CVIL)1 个研究点 分布在 1 个国家目标入组 46 人开始时间: 2022年9月26日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
46
试验地点
1
主要终点
overall ocular comfort

研究概览

简要总结

This study is being conducted to determine if scleral lenses treated with Hydra-PEG improve comfort and dryness.

详细描述

The objective of the study is to determine if scleral lenses with and scleral lenses without Hydra-PEG treatment provide positive improvement in ocular comfort and dryness scores.

The effect of the study lenses and the treatment, will be compared in a group of symptomatic soft lens wearers, and also in a group of symptomatic non contact lens wearers.

The primary outcome variable for this study is "overall ocular comfort" reported at the screening visit for the habitual vision correction, and at the 4-week follow-up visits for each of the two study lenses. using a 0-10 scale (0.5 steps).

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Other
盲法
Double (Participant, Investigator)

盲法说明

At the fitting visit, only uncoated lenses will be used to determine the parameters of the lenses to be ordered. At both dispense visits, participants and investigators will be masked to the lens type dispensed. In order to achieve this, unmasked study personnel will determine the order of lens wear according to the randomization schedule and they will not share the lens labels or packs with the investigator. Instead, the lenses will be transferred to an unmarked case/container prior to being provided at the Dispense visit.

入排标准

年龄范围
17 Years 至 70 Years(Child, Adult, Older Adult)
性别
All
接受健康志愿者
是

入选标准

  • •Are at least 17 years of age and have full legal capacity to volunteer;
  • •Have read and signed an information consent letter;
  • •Are willing and able to follow instructions and maintain the appointment schedule;
  • •Agree to wear the study scleral lenses for at least 8 hours per day, 5 days a week;
  • •Have a refraction between +20.00 and -20.00D and spectacle astigmatism of no more than -3.00DC in each eye;
  • •Have best corrected visual acuity of 20/40 or better in each eye with the study lenses;
  • •Demonstrate an acceptable fit with the study lenses;
  • •Have no active ocular disease or inflammation;
  • •Group 1: Habitual wearer of frequent replacement or daily disposable soft lenses;
  • •Group 2: Have not worn contact lenses for 6 months;
  • •Group 1: Contact lens wearers should score ≥12 on CLDEQ-8;
  • •Group 2: Non contact lens wearers should score ≥13 on OSDI.

排除标准

  • •Are participating in any concurrent clinical or research study, or have done so within the past 30 days;
  • •Cannot achieve a successful lens fit or vision with the study lens;
  • •Have been diagnosed with keratoconus or corneal distortion;
  • •Have any known active* ocular condition, disease and/or infection;
  • •Have a systemic or ocular condition that in the opinion of the investigator may affect a study outcome variable e.g. pingueculae;
  • •Are using any systemic or topical medications that in the opinion of the investigator may affect a study outcome variable;
  • •Group 2: Non-contact lens wearers who score ≥33 on OSDI and also demonstrate either corneal staining ≥3 (Oxford scale) or non-invasive tear break-up time ≤3 seconds#;
  • •Have known sensitivity to the diagnostic sodium fluorescein to be used in the study;
  • •Are pregnant, lactating or planning a pregnancy^ at the time of enrolment, by self report;
  • •Have undergone refractive error surgery;
  • •Are listed on the Delegation Log for this study.

研究组 & 干预措施

Habitual Soft Lens Wearers

Experimental

Each group will be a prospective, randomized, double masked, cross-over, 1-month per arm, daily wear study. Each participant will be active in the study for at least 2 months.

干预措施: scleral lens (Device)

Non Contact Lens Wearers

Experimental

Each group will be a prospective, randomized, double masked, cross-over, 1-month per arm, daily wear study. Each participant will be active in the study for at least 2 months.

干预措施: scleral lens (Device)

结局指标

主要结局

overall ocular comfort

时间窗: 4 weeks

reported at the screening visit for the habitual vision correction, and at the 4-week follow-up visits for each of the two study lenses. using a 0-10 scale (0.5 steps)

次要结局

未报告次要终点

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验